Search
Skip to Search Results- 4Löbenberg, Raimar
- 3Azarmi, Shirzad
- 3Roa, Wilson H.
- 2Al-Hallak, MHD Kamal
- 2Finlay, Warren H.
- 2Löbenberg, R.
- 12Graduate and Postdoctoral Studies (GPS), Faculty of
- 12Graduate and Postdoctoral Studies (GPS), Faculty of /Theses and Dissertations
- 6Pharmacy and Pharmaceutical Sciences, Faculty of
- 6Pharmacy and Pharmaceutical Sciences, Faculty of/Journal Articles (Pharmacy and Pharmaceutical Sciences)
- 1Nursing, Faculty of
- 1Nursing, Faculty of/Chronicity
- 3Department of Chemical and Materials Engineering
- 3Faculty of Pharmacy and Pharmaceutical Sciences
- 2Department of Biomedical Engineering
- 1Department of Chemistry
- 1Department of Surgery
- 1Medical Sciences- Laboratory Medicine and Pathology
- 1Burrell, Robert (Biomedical Engineering)
- 1Bédard, Eric (Surgery)
- 1Dr. Afsaneh Lavasanifar (Faculty of Pharmacy and Pharmaceutical Sciences)
- 1Lavasanifar, Afsaneh (Faculty of Pharmacy and Pharmaceutical Sciences)
- 1Le, Xiao-Chun Chris (Department of Laboratory Medicine and Pathology)
- 1Li, Xing-Fang (Laboratory Medicine and Pathology)
-
Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration
Download2003
Kubo, W., Takahashi, A., Miyazaki, S., Löbenberg, R., Bachynsky, J.
Abstract: Purpose: The aim of this work was to prepare poly n-butylcyanoacrylate (PNBCA) nanocapsules loaded with indomethacin and to evaluate the ability of this carrier system to deliver the drug systemically after its topical application. Methods: Poly n-butylcyanoacrylate (PNBCA) nanocapsules...
-
The changing causal foundations of cancer-related symptom clustering during the final month of palliative care: A longitudinal study
Download2008
Hanson, J., Hayduk, L., Quan, H., Olson, K., Strasser, F., Cui, Y., Lawlor, P., Cree, M.
Background: Symptoms tend to occur in what have been called symptom clusters. Early symptom cluster research was imprecise regarding the causal foundations of the coordinations between specific symptoms, and was silent on whether the relationships between symptoms remained stable over time. This...
-
Lipid Modified Polymers for Transfection of Human CRL Fibroblasts, and for siRNA Mediated MDR Reversal in Melanoma Cancer Therapy
DownloadFall 2010
Gene delivery for therapeutic purposes is quickly emerging as the best potential treatment option for inherited genetic diseases and cancer. Viral gene carriers have been the choice for this purpose due to their high efficiency, but harmful immunogenic and oncogenic host reactions have limited...
-
2010
Al-Hallak, K., Roa, W. H., Löbenberg, R., Azarmi, S., Magliocco, A. M., Finlay, W. H.
This is an abstract of a presentation made at the conference titled \"The Aerosol Society Drug Delivery to the Lungs 20,\" at the Edinburgh International Conference Centre, Scotland, UK, December 9-11, 2009.
-
Spring 2011
The objective of this thesis is to design nanoparticle (NP)-based drug delivery systems suitable for treatment of bone diseases. Two types of nanocarriers, (1) polymer coated bovine serum albumin (BSA) NPs and (2) lipid based NPs (micelles and liposomes) were investigated. The BSA NPs were...
-
Inhalable nanoparticles in lung cancer treatment; efficacy, safety, distribution and nanoparticle-macrophage interactions
DownloadFall 2012
In 2002, lung cancer was responsible for 17.6% of the total worldwide deaths from cancer. Beyond the three traditional forms of cancer treatment, surgery, radiation therapy, and chemotherapy, targeted drug delivery therapy has shown to be a potential treatment option. The design of a successful...